Related Experiment Video
Updated: May 12, 2025
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
Published on: July 22, 2020
Mechanistic Insights into Radiation Resistance in Colorectal Cancer: Gene Exploration Study
Beamjun Park1, Soohyeon Lee2, Inyoung Jo3
1Department of Medical Life Science, Soonchunhyang University, Asan 31538, Republic of Korea.
Abstract:
Radiotherapy is a cornerstone of colorectal cancer (CRC) treatment; however, its therapeutic efficacy is often compromised by both intrinsic and acquired resistance in CRC cells. This study employed small interfering RNA (siRNA) technology to elucidate the functional roles of BAMBI, GADD34, NFKBIA, and NFKBID in CRC cell lines SW480 and HCT116. We assessed their impact on key cellular processes and radiation sensitivity. Gene silencing of all four target genes significantly suppressed CRC cell proliferation, migration, and invasion. Moreover, siRNA-mediated knockdown enhanced radiation sensitivity, as evidenced by a substantial increase in apoptosis and a marked reduction in cell viability compared with controls. These findings suggest that BAMBI, GADD34, NFKBIA, and NFKBID serve as critical regulators of CRC progression and radiation resistance. Overall, this study provides a mechanistic foundation for further exploration into the pathways underlying radiation resistance and underscores the potential for developing personalized radiotherapy strategies guided by molecular profiling.
Insights
Targeting BAMBI, GADD34, NFKBIA, and NFKBID with siRNA enhances colorectal cancer (CRC) radiotherapy. Silencing these genes suppresses CRC progression and increases sensitivity to radiation, offering new strategies for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy Research
Background:
- Radiotherapy is a primary treatment for colorectal cancer (CRC).
- Therapeutic success is limited by intrinsic and acquired resistance in CRC cells.
- Identifying molecular targets to overcome resistance is crucial for improving treatment outcomes.
Purpose of the Study:
- To investigate the roles of BAMBI, GADD34, NFKBIA, and NFKBID in colorectal cancer progression and radiation resistance.
- To evaluate the impact of silencing these genes on CRC cell behavior and sensitivity to radiotherapy.
- To explore potential therapeutic targets for overcoming radioresistance in CRC.
Main Methods:
- Utilized small interfering RNA (siRNA) technology for gene silencing in SW480 and HCT116 colorectal cancer cell lines.
- Assessed the effects of gene knockdown on cell proliferation, migration, and invasion.
- Quantified changes in apoptosis and cell viability to determine radiation sensitivity.
Main Results:
- Gene silencing of BAMBI, GADD34, NFKBIA, and NFKBID significantly inhibited CRC cell proliferation, migration, and invasion.
- siRNA-mediated knockdown markedly enhanced radiation sensitivity.
- Knockdown led to increased apoptosis and reduced cell viability post-irradiation compared to control groups.
Conclusions:
- BAMBI, GADD34, NFKBIA, and NFKBID are critical regulators of colorectal cancer progression and radiation resistance.
- Targeting these genes represents a promising strategy to enhance radiotherapy efficacy.
- Findings provide a mechanistic basis for developing personalized radiotherapy approaches based on molecular profiling.
Related Concept Videos
02:56Treatment Resistant Cancers
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...